Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

David Ridley

Senior Editor – Europe

During his time at OTC bulletin, David focused mainly on the European OTC market, especially German-speaking countries: Germany, Austria and Switzerland). David is interested in European OTC, herbal/homeopathic, food supplement and self-care medical device regulation, and prescription-to-OTC switches in particular. Before working for OTC bulletin, David was a Lecturer in English and Journalism, and alongside his job David moonlights as a musician in a heavy metal band.

Latest From David Ridley

Digital Home-Testing Is The Future, Says Bloom Diagnostics Co-Founder Angelica Kohlmann

With its lateral flow at-home tests for ferritin, thyroid function and ovarian reserves, Swiss medtech firm Bloom Diagnostics thinks it has seen the future of consumer healthcare. HBW Insight speaks to co-founder and board chair Angelica Kohlmann about the firm's Bloom Lab technology and forward-looking plans, including a possible US launch. 

Wellness Artificial Intelligence

UK OTC Market Bounces Back In 2021 With Help Of Cold, Flu And Pain Categories

Thanks to double-digit growth in the cold and flu category and higher demand for analgesics, the UK’s OTC market grew by 4.5% to £2.87bn ($3.52bn), according to data from NielsenIQ. Looking ahead, Nielsen's consumer health expert Matt Carpenter suggests that consumers are now adopting "moving on" mindsets, which OTC firms need to take into account in their business strategies.

United Kingdom Health

CBD Supplements Safety: EU Two Years Behind UK

When it comes to assessing the safety of CBD in foods, the EU appears to be lagging behind the UK. Food Standards Agency CEO Emily Miles has noted that EFSA recently reached the same conclusions as the UK’s Committee on Toxicity did two years ago: there are still evidence gaps relating to CBD as a food. This may reassure UK operators that with the FSA further along in the assessment process it will not follow EFSA in suspending CBD novel food applications - but as expert Greer Deal notes, it's too soon to say. 

United Kingdom Wellness

EU's Highest Court Advised Prostaglandin Eyelash Serum Is Not A Medicine Per Se

Just because the use of a substance in a cosmetic product, in this case prostaglandin-derivative methylamide-dihydro-noralfaprostal, has a physiological effect does not mean it's a medicinal product by function, advises the Advocate General of the Court of Justice of the EU in a recent opinion. While the opinion does not bind the CJEU to any decision, it may impact discussions elsewhere with regards to these substances, for example in the US.

Europe Beauty

US Cardiac Arrhythmia Case Could Stoke International CBD Safety Worries

A patient admitted to a US emergency department after experiencing dizziness and fainting without warning is found to have been using a cocktail of herbal dietary supplements, including CBD and CBG. The case could fuel international worries about CBD's safety, for example in the EU, where novel food applications were recently put on hold by EFSA because of safety data gaps. 

US States Wellness

EU CBD Novel Food Applications On Hold As EFSA Considers Health Risks

All European Union CBD novel food applications have been paused by EFSA after its Panel on Nutrition, Novel Foods and Food Allergens raised concerns about the ingredient's safety, pointing in a wide-ranging scientific literature review to a number of data gaps related to bioavailability, liver damage, gastrointestinal issues and possible negative impacts on pregnancy and reproductive health.  

Europe Wellness
See All
UsernamePublicRestriction

Register